semaglutide black box warning The FDA sent a letter to the maker of Ozempic and Wegovy over unreported potential GLP-1 side effects. Here's what to know Semaglutide & weight loss –

Its almost never-ending. (The phenomenon of GLP-1s seemingly changing peoples skin is something Allure first reported on last summer.) Still, doctors generally agree that theres little hard evidenceas in, biopsy studies examining skin structure and function before and after GLP-1 useproving that these medications truly alter the tissues at a molecular level

Higher dose Wegovy demonstrates nearly 28% weight loss in early responders: sub-analysis of the STEP UP trial presented at the European Congress on Obesity (ECO)

It is especially relevant for patients taking or researching semaglutide, tirzepatide, GLP-1 injections, oral GLP-1 options, or physician-supervised weight loss programs

Eli Lilly, which manufactures Mounjaro a similar medication that is approved for treating diabetes but also induces weight loss announced on Sept

Investment in preventive dental care during GLP-1 treatment can prevent costly restorative work later

This was found to be even better than other drugs